Analyst Consensus ?
ConsensusHold35 ratings
Bullish1645.7%
Neutral1748.6%
Bearish25.7%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Stanley Black & Decker, Inc. (SWK) analyst consensus, price targets, and firm-level rating history from FN2 Research.
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jun 18, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 1, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 1, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 6, 2026 |
| UBS | Buy | Buy | Maintain | Jan 5, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jul 8, 2025 |
| Mizuho | Outperform | Neutral | Upgrade | Dec 19, 2024 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 10, 2024 |
| Zelman & Assoc | Buy | Hold | Upgrade | Aug 18, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Feb 6, 2023 |
| Longbow Research | Neutral | Buy | Downgrade | Feb 3, 2023 |
| Vertical Research | Hold | Buy | Downgrade | Jul 29, 2022 |
| B of A Securities | Underperform | Underperform | Maintain | Mar 9, 2022 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jun 17, 2021 |
| Nomura Instinet | Buy | Buy | Maintain | May 4, 2020 |
| Nomura | Buy | Buy | Maintain | May 4, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Jan 31, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Jan 31, 2020 |
| Bank of America | Buy | Underperform | Upgrade | Nov 14, 2019 |
| Zelman | Hold | Buy | Downgrade | Oct 25, 2019 |
| Keybanc | Overweight | Downgrade | Sep 18, 2019 | |
| Macquarie | Outperform | Outperform | Maintain | Sep 6, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| MKM Partners | Buy | Buy | Maintain | Jan 25, 2018 |
| FBR Capital | Buy | Buy | Maintain | Oct 25, 2017 |
| Wunderlich Securities | Buy | Buy | Maintain | Oct 27, 2016 |
| Wunderlich | Buy | Buy | Maintain | Oct 27, 2016 |
| Susquehanna | Positive | Positive | Maintain | Apr 14, 2016 |
| Imperial Capital | In Line | In Line | Maintain | Jan 29, 2016 |
| Argus Research | Hold | Buy | Downgrade | May 30, 2013 |
| CLSA | Buy | Buy | Maintain | Feb 26, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Dec 20, 2012 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 18, 2012 |
Upside is calculated against the persisted current price $95.6. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Joe Ritchie | $93 | $93.05 | -2.7% | Jul 29, 2026 |
| Morgan Stanley | Christopher Snyder | $84 | $79.76 | -12.1% | May 28, 2026 |
| Robert W. Baird | Analyst unavailable | $84 | $75.89 | -12.1% | Apr 30, 2026 |
| Robert W. Baird | Timothy Wojs | $82 | $75.12 | -14.2% | Apr 21, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $87.29 | -9.0% | Feb 23, 2026 |
| Goldman Sachs | Joe Ritchie | $84 | $85.57 | -12.1% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $100 | $84.63 | +4.6% | Feb 5, 2026 |
| Wells Fargo | Joseph O'Dea | $82 | $82.9 | -14.2% | Jan 14, 2026 |
| UBS | Analyst unavailable | $98 | $77.34 | +2.5% | Jan 5, 2026 |
| Robert W. Baird | Timothy Wojs | $85 | $75.24 | -11.1% | Dec 23, 2025 |
| Morgan Stanley | Analyst unavailable | $88 | $76.02 | -7.9% | Dec 22, 2025 |
| Morgan Stanley | Christopher Snyder | $80 | $65.38 | -16.3% | Oct 14, 2025 |
| Jefferies | Jonathan Matuszewski | $86 | $74.54 | -10.0% | Aug 18, 2025 |
| Goldman Sachs | Analyst unavailable | $80 | $67.77 | -16.3% | Jul 30, 2025 |
| Robert W. Baird | Timothy Wojs | $65 | $58.94 | -32.0% | May 1, 2025 |
| Wells Fargo | Joseph O'Dea | $60 | $58.94 | -37.2% | May 1, 2025 |
| Wells Fargo | Joseph O'Dea | $90 | $81.65 | -5.9% | Jan 7, 2025 |
| Goldman Sachs | Joe Ritchie | $94 | $93.87 | -1.7% | Oct 30, 2024 |
| Morgan Stanley | Jonathan Sakraida | $115 | $96.64 | +20.3% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $107 | $98.36 | +11.9% | Sep 6, 2024 |
| Robert W. Baird | Timothy Wojs | $94 | $106.05 | -1.7% | Jul 31, 2024 |
| Wells Fargo | Joseph O'Dea | $110 | $106.05 | +15.1% | Jul 31, 2024 |
| Robert W. Baird | Timothy Wojs | $80 | $86.95 | -16.3% | Jul 22, 2024 |
| Morgan Stanley | Julian Mitchell | $86 | $86.99 | -10.0% | Jun 4, 2024 |
| Barclays | Julian Mitchell | $107 | $95.46 | +11.9% | Apr 2, 2024 |
| Barclays | Julian Mitchell | $105 | $95.32 | +9.8% | Jan 31, 2024 |
| Morgan Stanley | Dan Oppenheim | $125 | $101.64 | +30.8% | Aug 15, 2022 |
| Wells Fargo | Joseph O'Dea | $105 | $97.33 | +9.8% | Aug 1, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $137 | $114.53 | +43.3% | Jun 6, 2022 |
| Morgan Stanley | Analyst unavailable | $150 | $126.44 | +56.9% | Apr 29, 2022 |
| Citigroup | Analyst unavailable | $110 | $125.83 | +15.1% | Apr 29, 2022 |
| Wells Fargo | Analyst unavailable | $158 | $127.78 | +65.3% | Apr 29, 2022 |
| Robert W. Baird | Timothy Wojs | $188 | $126.9 | +96.7% | Apr 29, 2022 |
| Credit Suisse | Daniel Oppenheim | $165 | $140.92 | +72.6% | Apr 10, 2022 |
| Barclays | Julian Mitchell | $180 | $141.6 | +88.3% | Apr 5, 2022 |
| Bank of America Securities | Ross Gilardi | $140 | $148.4 | +46.5% | Mar 16, 2022 |
| UBS | Markus Mittermaier | $248 | $173.47 | +159.4% | Feb 2, 2022 |
| Deutsche Bank | Nicole Deblase | $223 | $187.17 | +133.3% | Jan 10, 2022 |
| Wolfe Research | Nigel Coe | $246 | $192.86 | +157.3% | Jul 28, 2021 |
Track every rating change on SWK the moment it posts. Free to start.
Start free